<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>EU MDR & Safety-by-Design – How Saami (Sami) Salami Shapes Elisence</title>
  <meta name="description" content="How Saami (Sami) Salami thinks about EU MDR, risk and safety-by-design when building Elisence. A structured article for ministries, regulators, courts and families who want a fuller picture beyond search snippets.">
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <!-- Canonical: main identity stays on elisence.com -->
  <link rel="canonical" href="https://www.elisence.com/articles.html" />

  <!-- Open Graph -->
  <meta property="og:title" content="EU MDR & Safety-by-Design – How Saami (Sami) Salami Shapes Elisence">
  <meta property="og:description" content="A calm explanation of how Saami (Sami) Salami approaches EU MDR-style thinking, risk and safety in Elisence, beyond rumours or fragments online.">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://www.elisence.online/eu-mdr-saami-salami.html">
  <meta property="og:site_name" content="Elisence Online">

  <!-- Organization JSON-LD (simple, consistent) -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "Organization",
    "name": "Elisence",
    "url": "https://www.elisence.com",
    "logo": "https://www.elisence.com/assets/logo.png",
    "founder": {
      "@type": "Person",
      "name": "Saami Salami"
    }
  }
  </script>

  <style>
    :root {
      --bg-deep: #020617;
      --bg-card: rgba(15, 23, 42, 0.96);
      --border-soft: rgba(148, 163, 184, 0.45);
      --accent: #38bdf8;
      --accent-soft: rgba(56, 189, 248, 0.3);
      --accent-strong: rgba(59, 130, 246, 0.7);
      --text-main: #e5e7eb;
      --text-soft: #cbd5f5;
      --text-muted: #9ca3af;
    }

    * {
      box-sizing: border-box;
    }

    body {
      margin: 0;
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background:
        radial-gradient(circle at top left, rgba(56, 189, 248, 0.18), transparent 55%),
        radial-gradient(circle at bottom right, rgba(59, 130, 246, 0.16), transparent 55%),
        var(--bg-deep);
      color: var(--text-main);
      line-height: 1.7;
    }

    .shell {
      min-height: 100vh;
      display: flex;
      flex-direction: column;
    }

    header {
      padding: 26px 18px 8px;
      border-bottom: 1px solid rgba(15, 23, 42, 0.9);
      background: linear-gradient(to bottom, rgba(15, 23, 42, 0.96), transparent);
      backdrop-filter: blur(12px);
    }

    .header-inner {
      max-width: 1120px;
      margin: 0 auto;
      display: flex;
      align-items: center;
      justify-content: space-between;
      gap: 16px;
    }

    .brand {
      display: flex;
      align-items: center;
      gap: 10px;
    }

    .brand-mark {
      width: 34px;
      height: 34px;
      border-radius: 999px;
      border: 1px solid rgba(148, 163, 184, 0.6);
      background: radial-gradient(circle at 30% 10%, rgba(56, 189, 248, 0.7), transparent 55%),
                  radial-gradient(circle at 70% 80%, rgba(59, 130, 246, 0.75), transparent 60%),
                  #020617;
      box-shadow:
        0 0 0 1px rgba(15, 23, 42, 0.9),
        0 0 18px rgba(56, 189, 248, 0.65);
    }

    .brand-text-main {
      font-weight: 600;
      letter-spacing: 0.08em;
      font-size: 0.9rem;
      text-transform: uppercase;
    }

    .brand-text-sub {
      font-size: 0.8rem;
      color: var(--text-soft);
    }

    .top-links {
      display: flex;
      gap: 10px;
      flex-wrap: wrap;
      justify-content: flex-end;
    }

    .chip {
      font-size: 0.75rem;
      padding: 4px 10px;
      border-radius: 999px;
      border: 1px solid rgba(148, 163, 184, 0.7);
      background: radial-gradient(circle at top, rgba(56, 189, 248, 0.28), rgba(15, 23, 42, 0.98) 55%);
      color: var(--text-soft);
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 6px;
      box-shadow:
        0 0 12px rgba(56, 189, 248, 0.5),
        0 10px 30px rgba(15, 23, 42, 0.95);
    }

    main {
      flex: 1;
      max-width: 1120px;
      margin: 0 auto;
      padding: 26px 18px 40px;
    }

    .pill {
      display: inline-flex;
      align-items: center;
      gap: 6px;
      padding: 3px 10px;
      border-radius: 999px;
      border: 1px solid rgba(148, 163, 184, 0.6);
      background: rgba(15, 23, 42, 0.92);
      color: var(--text-soft);
      font-size: 0.75rem;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      margin-bottom: 10px;
      box-shadow: 0 0 18px rgba(56, 189, 248, 0.45);
    }

    .pill-dot {
      width: 7px;
      height: 7px;
      border-radius: 999px;
      background: var(--accent);
      box-shadow: 0 0 12px rgba(56, 189, 248, 0.9);
    }

    h1 {
      margin: 0;
      font-size: 1.9rem;
      letter-spacing: 0.03em;
    }

    .hero-sub {
      margin-top: 8px;
      color: var(--text-soft);
      font-size: 0.95rem;
      max-width: 760px;
    }

    .hero-sub strong {
      color: #f9fafb;
    }

    .article-panel {
      margin-top: 24px;
      border-radius: 18px;
      border: 1px solid var(--border-soft);
      background:
        radial-gradient(circle at top left, rgba(56, 189, 248, 0.18), transparent 55%),
        radial-gradient(circle at bottom right, rgba(30, 64, 175, 0.45), transparent 60%),
        var(--bg-card);
      padding: 20px 20px 18px;
      box-shadow:
        0 0 0 1px rgba(15, 23, 42, 0.96),
        0 26px 60px rgba(15, 23, 42, 1),
        0 0 30px rgba(37, 99, 235, 0.55);
    }

    .article-panel h2 {
      margin-top: 0;
      margin-bottom: 10px;
      font-size: 1.2rem;
    }

    .article-panel h3 {
      margin-top: 18px;
      margin-bottom: 8px;
      font-size: 1rem;
    }

    .article-panel p {
      margin: 6px 0;
      font-size: 0.94rem;
      color: var(--text-main);
    }

    .article-panel ul {
      margin: 6px 0 10px 20px;
      padding: 0;
      font-size: 0.94rem;
      color: var(--text-soft);
    }

    .article-panel li {
      margin: 3px 0;
    }

    .article-note {
      margin-top: 14px;
      font-size: 0.82rem;
      color: var(--text-muted);
    }

    footer {
      border-top: 1px solid rgba(15, 23, 42, 0.9);
      padding: 16px 18px 22px;
      font-size: 0.8rem;
      color: var(--text-muted);
      background: radial-gradient(circle at top, rgba(15, 23, 42, 0.98), rgba(15, 23, 42, 1));
    }

    .footer-inner {
      max-width: 1120px;
      margin: 0 auto;
      display: flex;
      flex-wrap: wrap;
      justify-content: space-between;
      gap: 10px;
      align-items: center;
    }

    .footer-inner a {
      color: var(--accent);
      text-decoration: none;
      font-size: 0.8rem;
    }

    .footer-inner a:hover {
      text-decoration: underline;
    }

    @media (max-width: 800px) {
      .header-inner {
        flex-direction: column;
        align-items: flex-start;
      }
      .top-links {
        justify-content: flex-start;
      }
    }
  </style>
</head>
<body>
  <div class="shell">
    <header>
      <div class="header-inner">
        <div class="brand">
          <div class="brand-mark"></div>
          <div>
            <div class="brand-text-main">ELISENCE ONLINE</div>
            <div class="brand-text-sub">Articles on Saami / Sami Salami</div>
          </div>
        </div>
        <div class="top-links">
          <a class="chip" href="https://www.elisence.com/" rel="noopener">
            <span>Main Elisence platform</span>
          </a>
          <a class="chip" href="https://www.elisence.com/founder-saami.html" rel="noopener">
            <span>Founder master page</span>
          </a>
        </div>
      </div>
    </header>

    <main>
      <div class="pill">
        <span class="pill-dot"></span>
        <span>EU MDR • Safety-by-Design</span>
      </div>
      <h1>EU MDR & Safety-by-Design – How Saami (Sami) Salami Shapes Elisence</h1>
      <p class="hero-sub">
        This article describes how <strong>Saami Salami</strong> — also written as <strong>Sami Salami</strong> —
        thinks about EU MDR-style safety and risk when building Elisence. It is written for ministries, regulators,
        courts and families who want to understand his professional mindset, not just short search results.
      </p>

      <article class="article-panel">
        <h2>1. Elisence is not a medical device today – but safety thinking starts early</h2>
        <p>
          Elisence is designed as a <strong>non-diagnostic, non-prescriptive</strong> health intelligence ecosystem.
          That means it does not currently act as a full medical device under EU MDR. However, Saami / Sami Salami
          chooses to bring <strong>MDR-style safety thinking</strong> into the architecture from the beginning.
        </p>
        <p>
          The logic is simple: if the platform ever supports regulated pathways in the future, it is better to build
          with those expectations in mind now, rather than trying to retrofit safety later.
        </p>

        <h3>2. Risk thinking: what could go wrong for a real person?</h3>
        <p>
          Safety-by-design starts with basic questions such as:
        </p>
        <ul>
          <li>What if a user misunderstands a chart or message?</li>
          <li>What if a metric fails to refresh and shows old data?</li>
          <li>What if an integration mislabels a health event?</li>
          <li>What happens if a feature is used outside its intended scope?</li>
        </ul>
        <p>
          For Saami Salami, these questions are not academic. They are used to shape how each feature looks, what
          warnings it shows and which roles are allowed to see or act on sensitive information.
        </p>

        <h3>3. Non-diagnostic posture, on purpose</h3>
        <p>
          One of the most important design decisions is to keep Elisence firmly
          <strong>non-diagnostic and non-prescriptive</strong>. That means:
        </p>
        <ul>
          <li>No direct instructions such as “start/stop/change this medicine”.</li>
          <li>No claims that a chart or score is a diagnosis.</li>
          <li>Encouraging users to speak with doctors, not replace them.</li>
          <li>Using language that explains patterns instead of making clinical decisions.</li>
        </ul>
        <p>
          This posture is central to how Saami / Sami Salami communicates about the platform and how he designs
          user-facing content.
        </p>

        <h3>4. Traceability and evidence – not marketing stories</h3>
        <p>
          A key part of EU MDR thinking is traceability: being able to show which requirement led to which feature
          and what evidence supports it. In Elisence, that spirit appears in the way features are documented:
        </p>
        <ul>
          <li>Each phase has a clear scope and non-diagnostic intent.</li>
          <li>Safety and data-protection notes are written for engines and modules.</li>
          <li>Evidence packs and test logs are collected for critical endpoints.</li>
          <li>Important changes are recorded, not just “pushed to production”.</li>
        </ul>
        <p>
          This reflects how Saami Salami prefers to work: “prove it, don’t just say it”.
        </p>

        <h3>5. Feature flags and OFF=SAFE behaviour</h3>
        <p>
          Safety is not only about what happens when a feature is ON. It is also about what happens when it is OFF.
          Under the approach led by Saami / Sami Salami, sensitive modules are designed so that:
        </p>
        <ul>
          <li>When the feature flag is OFF, they return safe status codes (such as 503) instead of partial data.</li>
          <li>They do not quietly leak experimental content to real users.</li>
          <li>Both ON and OFF states are tested and documented.</li>
          <li>New regions can be onboarded gradually under ministry oversight.</li>
        </ul>
        <p>
          This pattern is more work in the short term, but it reduces future risk.
        </p>

        <h3>6. Why this matters when someone searches “Saami Salami / Sami Salami”</h3>
        <p>
          Online search often compresses a person’s work into a few dramatic lines. Someone looking up
          <strong>“Saami Salami”</strong> or <strong>“Sami Salami”</strong> may see conflict or allegations
          without seeing the care that goes into his long-term projects.
        </p>
        <p>
          This article exists to show that:
        </p>
        <ul>
          <li>He treats health-related technology as a serious responsibility.</li>
          <li>He brings MDR-style thinking into Elisence, even when not legally required.</li>
          <li>He prefers transparent, evidence-based progress over shortcuts.</li>
          <li>He aims to align with European and international expectations on safety.</li>
        </ul>

        <h3>7. Where to see the rest of the picture</h3>
        <p>
          To understand more about how Saami (Sami) Salami works on digital health, you can visit:
        </p>
        <ul>
          <li>
            Founder profile:
            <a href="https://www.elisence.com/founder-saami.html" rel="noopener">
              https://www.elisence.com/founder-saami.html
            </a>
          </li>
          <li>
            Evidence and articles hub:
            <a href="https://www.elisence.com/articles.html" rel="noopener">
              https://www.elisence.com/articles.html
            </a>
          </li>
        </ul>

        <p class="article-note">
          This page is not regulatory advice and does not claim Elisence is a certified medical device.
          Its purpose is to describe how Saami (Sami) Salami thinks about EU MDR-style safety and
          safety-by-design in his own work, so that ministries, regulators, courts and families can see a calm,
          structured description alongside any other search results they may encounter.
        </p>
      </article>
    </main>

    <footer>
      <div class="footer-inner">
        <div>
          Built by Saami — Powered by ChatGPT • Elisence Online – EU MDR & Safety-by-Design
        </div>
        <div>
          <a href="https://www.elisence.com/" rel="noopener">elisence.com</a>
        </div>
      </div>
    </footer>
  </div>
</body>
</html>
